Skip to main content
First page of PDF

Get full access to this article

View all available purchase options and get full access to this article.

Supplemental Material

File (circhf_circhf-2023-010719_supp2.pdf)
File (circhf_circhf-2023-010719_supp3.mp4)
File (circhf_circhf-2023-010719_supp4.mp4)
File (circhf_circhf-2023-010719_supp5.mp4)

REFERENCES

1.
Truby LK, Garan AR, Givens RC, Wayda B, Takeda K, Yuzefpolskaya M, Colombo PC, Naka Y, Takayama H, Topkara VK. Aortic insufficiency during contemporary left ventricular assist device support: analysis of the INTERMACS registry. JACC Heart Fail. 2018;6:951–960. doi: 10.1016/j.jchf.2018.07.012
2.
Purita PAM, Tahoces LS, Fraccaro C, Nai Fovino L, Kim WK, Espada-Guerreiro C, De Backer O, Seiffert M, Nombela-Franco L, Gomez RM, et al. Transcatheter treatment of native aortic valve regurgitation: results from an international registry using the transfemoral ACURATE neo valve. Int J Cardiol Hear Vasc. 2020;27:100480. doi: 10.1016/j.ijcha.2020.100480
3.
Dimarakis I, Callan P, Khorsandi M, Pal JD, Bravo CA, Mahr C, Keenan JE. Pathophysiology and management of valvular disease in patients with destination left ventricular assist devices. Front Cardiovasc Med. 2022;9:1029825. doi: 10.3389/fcvm.2022.1029825
4.
Fried JA, Nazif TM, Colombo PC. A new frontier for TAVR: aortic insufficiency in CF-LVAD patients. J Heart Lung Transplant. 2019;38:927–929. doi: 10.1016/j.healun.2019.06.024
5.
Mondal S, Dawood M, Bandyopadhyay D, Taylor BS, Tanaka K, Gupta A. Transcatheter aortic valve replacement: a potential option for aortic insufficiency management in patients with left ventricular assist device. Int J Cardiol Hear Vasc. 2020;26:100425. doi: 10.1016/j.ijcha.2019.100425
6.
Zaidi SH, Minhas AMK, Sagheer S, ManeshGangwani K, Dani SS, Goel SS, Alam M, Sheikh AB, Hirji S, Wasty N. Clinical outcomes of transcatheter aortic valve replacement (TAVR) vs surgical aortic valve replacement (SAVR) in patients with durable left ventricular assist device (LVAD). Curr Probl Cardiol. 2022;47:101313. doi: 10.1016/j.cpcardiol.2022.101313
7.
Rali AS, Taduru SS, Tran LE, Ranka S, Schlendorf KH, Barker CM, Shah AS, Lindenfeld J, Zalawadiya SK. Transcatheter aortic valve replacement and surgical aortic valve replacement outcomes in left ventricular assist device patients with aortic insufficiency. Card Fail Rev. 2022;8:e30. doi: 10.15420/cfr.2022.21
8.
Dhillon AS, Jones BM, Hodson RW, Korngold EC. Transcatheter aortic valve replacement for severe aortic regurgitation in patients with a left ventricular assist device. J Invasive Cardiol. 2022;34:E369–E373.
9.
Phan K, Haswell JM, Xu J, Assem Y, Mick SL, Kapadia SR, Cheung A, Ling FS, Yan TD, Tchantchaleishvili V. Percutaneous transcatheter interventions for aortic insufficiency in continuous-flow left ventricular assist device patients: a systematic review and meta-analysis. ASAIO J. 2017;63:117–122. doi: 10.1097/MAT.0000000000000447
10.
Blanke P, Pibarot P, Hahn R, Weissman N, Kodali S, Thourani V, Parvataneni R, Dvir D, Naoum C, Nørgaard BL, et al. Computed tomography-based oversizing degrees and incidence of paravalvular regurgitation of a new generation transcatheter heart valve. JACC Cardiovasc Interv. 2017;10:810–820. doi: 10.1016/j.jcin.2017.02.021

Information & Authors

Information

Published In

Go to Circulation: Heart Failure
Go to Circulation: Heart Failure
Circulation: Heart Failure
Pages: e010719
PubMed: 38214151

Versions

You are viewing the most recent version of this article.

History

Published online: 12 January 2024
Published in print: February 2024

Permissions

Request permissions for this article.

Keywords

  1. aortic valve
  2. feasibility studies
  3. humans
  4. prosthesis failure
  5. transcatheter aortic valve replacement

Subjects

Authors

Affiliations

Department of Cardiology, University Hospital Ramón y Cajal, Madrid, Spain.
Luisa Salido Tahoces, MD, PhD
Department of Cardiology, University Hospital Ramón y Cajal, Madrid, Spain.
Marta Jiménez-Blanco Bravo, MD
Department of Cardiology, University Hospital Ramón y Cajal, Madrid, Spain.
Jesús Álvarez García, MD, PhD
Department of Cardiology, University Hospital Ramón y Cajal, Madrid, Spain.
José Luis Zamorano Gómez, MD, PhD
Department of Cardiology, University Hospital Ramón y Cajal, Madrid, Spain.
Ángel Sánchez Recalde, MD, PhD
Department of Cardiology, University Hospital Ramón y Cajal, Madrid, Spain.

Notes

For Sources of Funding and Disclosures, see page 183.
Supplemental Material is available at Supplemental Material.
Correspondence to: Ana Pardo Sanz, MD, PhD, Department of Cardiology, University Hospital Ramón y Cajal, Ctra. Colmenar Viejo Km 9.1, 28034 Madrid, Spain. Email [email protected]

Disclosures

Disclosures None.

Sources of Funding

None.

Metrics & Citations

Metrics

Citations

Download Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Select your manager software from the list below and click Download.

View Options

Login options

Check if you have access through your login credentials or your institution to get full access on this article.

Personal login Institutional Login
Purchase Options

Purchase this article to access the full text.

Purchase access to this article for 24 hours

TAVI With ACURATE neo2 Valve in Aortic Regurgitation Due to Left Ventricular Assist Device: A Custom-Made Option
Circulation: Heart Failure
  • Vol. 17
  • No. 2

Purchase access to this journal for 24 hours

Circulation: Heart Failure
  • Vol. 17
  • No. 2
Restore your content access

Enter your email address to restore your content access:

Note: This functionality works only for purchases done as a guest. If you already have an account, log in to access the content to which you are entitled.

View options

PDF and All Supplements

Download PDF and All Supplements

PDF/EPUB

View PDF/EPUB

Full Text HTML

View Full Text HTML

Figures

Tables

Media

Share

Share

Share article link

Share

Comment Response